Last reviewed · How we verify
NCT03333863
Bacterial and Antimicrobial Susceptibility Profile and the Prevalence of Different Sites of Infection(BASPP)
trial testing descriptive study which reviewed the data of patients hospitalized with positive bacterial cultures in Infectious Diseases in Pneumonia,Nephropyelitis,Angiocholitis or Others in 1,889 participants. Completed in 31 October 2019.
30 June 2018
Quick facts
| Lead sponsor | Shengjing Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,889 |
| Start date | 25 October 2017 |
| Primary completion | 30 June 2018 |
| Estimated completion | 31 October 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- descriptive study which reviewed the data of patients hospitalized with positive bacterial cultures
Conditions studied
- Infectious Diseases in Pneumonia,Nephropyelitis,Angiocholitis or Others — all drugs for Infectious Diseases in Pneumonia,Nephropyelitis,Angiocholitis or Others →
- Positive Bacterial Cultures Results of the Medical Records — all drugs for Positive Bacterial Cultures Results of the Medical Records →
Sponsor
Shengjing Hospital
Who can join
Eligibility, any sex, with Infectious Diseases in Pneumonia,Nephropyelitis,Angiocholitis or Others or Positive Bacterial Cultures Results of the Medical Records. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Positive results of bacterial culture are analyzed comprehensively in Shengjing Hospital of China Medical University in recent 3 years（between 2015- 2017）
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03333863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shengjing Hospital trials
Trials by the same sponsor.
- NCT07484763 — Predicting Recurrence in HR+/HER2- Early Breast Cancer · not yet recruiting
- NCT07497191 — AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer · not yet recruiting
- NCT07320599 — Neuroendoscopic Surgery With Ommaya Reservoir Implantation vs. Burr Hole Drainage for Infantile Postmeningitis Subdural · not yet recruiting
- NCT07153783 — Interventional AI-Human Collaboration for Liver Tumor Diagnosis · NA · completed
- NCT07101614 — A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chem · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03333863 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shengjing Hospital
- Last refreshed: 19 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03333863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing